tiprankstipranks
Advertisement
Advertisement

KAPA Stock Latest News

Kairos Pharma Highlights Clinical Programs at LD Micro
Company AnnouncementsKairos Pharma Highlights Clinical Programs at LD Micro
5d ago
8K
KAPA
Expanding Lung Cancer Franchise and Strategic Asset Acquisition Support Buy Rating on Kairos Pharma
PremiumRatings
Expanding Lung Cancer Franchise and Strategic Asset Acquisition Support Buy Rating on Kairos Pharma
2M ago
KAPA
Kairos Pharma Acquires Rights to AI-Discovered EGFR Therapy
PremiumCompany Announcements
Kairos Pharma Acquires Rights to AI-Discovered EGFR Therapy
3M ago
8K
KAPA
Kairos Pharma to acquire CL-273 from Celyn Therapeutics
PremiumThe Fly
Kairos Pharma to acquire CL-273 from Celyn Therapeutics
3M ago
KAPA
Kairos Pharma to acquire to two clinical-stage oncology assets from Celyn
PremiumThe Fly
Kairos Pharma to acquire to two clinical-stage oncology assets from Celyn
3M ago
KAPA
Kairos Pharma Expands Lung Cancer Pipeline With Celyn Deal
PremiumCompany AnnouncementsKairos Pharma Expands Lung Cancer Pipeline With Celyn Deal
3M ago
8K
KAPA
Kairos Pharma files $75M mixed securities shelf
Premium
The Fly
Kairos Pharma files $75M mixed securities shelf
4M ago
KAPA
Kairos Pharma’s Promising Clinical Developments and Strategic Focus Drive Buy Rating
Premium
Ratings
Kairos Pharma’s Promising Clinical Developments and Strategic Focus Drive Buy Rating
6M ago
KAPA
Kairos Pharma Approves RSUs and Cash Bonuses
PremiumCompany Announcements
Kairos Pharma Approves RSUs and Cash Bonuses
7M ago
8K
KAPA
Promising Developments in Kairos Pharma’s Lead Candidate ENV-105 Drive Buy Rating
PremiumRatings
Promising Developments in Kairos Pharma’s Lead Candidate ENV-105 Drive Buy Rating
8M ago
KAPA
Kairos Pharma to Present at ESMO Congress 2025
PremiumCompany Announcements
Kairos Pharma to Present at ESMO Congress 2025
8M ago
8K
KAPA
Promising Phase 2 Results and Safety Profile of ENV-105 Bolster Buy Rating for Kairos Pharma
PremiumRatings
Promising Phase 2 Results and Safety Profile of ENV-105 Bolster Buy Rating for Kairos Pharma
8M ago
KAPA
Kairos Pharma Reports Positive Phase 2 Trial Results
PremiumCompany AnnouncementsKairos Pharma Reports Positive Phase 2 Trial Results
8M ago
8K
KAPA
Kairos Pharma announces interim efficacy analysis of ENV105
Premium
The Fly
Kairos Pharma announces interim efficacy analysis of ENV105
8M ago
KAPA
Kairos Pharma’s Promising Developments and Positive Trial Data Reinforce Buy Recommendation
Premium
Ratings
Kairos Pharma’s Promising Developments and Positive Trial Data Reinforce Buy Recommendation
8M ago
KAPA
Kairos Pharma to Host KOL Event on Phase 2 Trial
PremiumCompany Announcements
Kairos Pharma to Host KOL Event on Phase 2 Trial
8M ago
8K
KAPA
Kairos Pharma Presents Phase 1 Data at Conference
PremiumCompany Announcements
Kairos Pharma Presents Phase 1 Data at Conference
9M ago
8K
KAPA
Kairos Pharma: Promising Drug Pipeline and Upcoming Catalysts Drive Buy Rating
PremiumRatings
Kairos Pharma: Promising Drug Pipeline and Upcoming Catalysts Drive Buy Rating
9M ago
KAPA
Optimistic Buy Rating for Kairos Pharma Driven by Promising Clinical Developments and Strong Safety Profile
PremiumRatings
Optimistic Buy Rating for Kairos Pharma Driven by Promising Clinical Developments and Strong Safety Profile
9M ago
KAPA
Kairos Pharma management to meet with Maxim
PremiumThe FlyKairos Pharma management to meet with Maxim
10M ago
KAPA
Why Is Kairos Pharma Stock (KAPA) Up 170% Today?
Premium
Market News
Why Is Kairos Pharma Stock (KAPA) Up 170% Today?
10M ago
KAPA
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
10M ago
ZK
AMD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >